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Stress protein activation by the cyclopentenone prostaglandin
15-deoxy-∆12,14-prostaglandin J2 in human mesangial cells.
Background. The cyclopentenone prostaglandin 15-deoxy-
12,14-prostaglandin J2 (15dPGJ2) affects mesangial prolifer-
ation, survival and production of proinflammatory proteins.
During a survey of the mesangial cell proteome after treatment
with 15dPGJ2, heat shock protein 70 (HSP70) was found to be
the most conspicuously up-regulated protein, suggesting that
stress proteins are key mediators or modulators of the effects
of 15dPGJ2. Because cyclopentenone prostaglandins are highly
reactive toward intracellular thiols, the role of intracellular thiol
modification in the stress response to 15dPGJ2 was examined.
Methods. Human mesangial cells were treated with 15dPGJ2
and intracellular thiol status was monitored by the fluores-
cent thiol probe monobromobimane (MBB). Specific intracel-
lular thiol pools were manipulated by treating the cells with
buthionine sulfoximine (BSO) to deplete glutathione (GSH),
or phenylarsine oxide (PAO) to modify protein vicinal dithiols.
Transcription pathways were examined with reporter gene or
adenoviral constructs.
Results. 15dPGJ2 decreased mesangial GSH and other in-
tracellular thiols, but depletion of GSH specifically with BSO
did not induce HSP70. Thiol-replenishing reagents, which
can restore modified protein thiols, attenuated 15dPGJ2-
induced HSP70 levels. Furthermore, PAO mimicked the effects
of 15dPGJ2 on HSP70. 15dPGJ2 also activated the stress-
responsive transcription factor Nrf2, which requires thiol mod-
ification of its cytoplasmic inhibitor protein for transcriptional
activity, and induced the Nrf2-dependent stress protein heme
oxygenase-1 (HO-1).
Conclusion. 15dPGJ2 activates a stress response in hu-
man mesangial cells by covalent modification of protein thiols
through its unique cyclopentenone ring structure. This stress re-
sponse may be beneficial in preventing renal cell injury or death
during kidney inflammation or ischemia.
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The well-established role of arachidonic acid metabo-
lites such as thromboxane A2, prostaglandin E2, and
prostacyclin in renal physiology and pathophysiology
[1–3] has prompted evaluation of other members of this
large family of lipid mediators for involvement in renal
disease. Most recently, cyclopentenone prostaglandins,
particularly those derived from prostaglandin D2
(PGD2), have generated considerable interest. One of
these, PGJ2, is a dehydration product of PGD2 in aqueous
environments, and can be further nonenzymatically me-
tabolized to 15-deoxy-12,14-prostaglandin J2 (15dPGJ2)
[4, 5]. Cyclopentenones are distinguished from other
prostaglandins by the presence of an a,b-unsaturated ke-
tone group in the cyclopentane ring.
J-series prostaglandins have a wide range of ef-
fects on intrinsic renal cells. 15dPGJ2 and PGJ2 are
anti-inflammatory, in that they block interleukin-1b
(IL-1b)-mediated activation of the proinflammatory
transcription factor nuclear factor-jB (NF-jB), and in-
duction of the chemokine monocyte chemoattractrant
protein-l (MCP-1) in human mesangial cells [6]. 15dPGJ2
and PGJ2 also activate mesangial extracellular signal-
related kinase [7]. At low concentrations 15dPGJ2 stim-
ulates mesangial proliferation, but causes cell death, in
part through apoptosis, at higher doses [8]. In contrast,
15dPGJ2 mainly causes apoptosis in human proximal
tubular epithelial cells [9].
Limited evidence also supports intra-renal production
of cyclopentenone prostaglandins. Mesangial cells can
make PGD2 and PGJ2 in response to proinflammatory
cytokines [10, 11], and 12-PGJ2, a precursor of 15dPGJ2,
is found in normal human urine [12]. 15dPGJ2 has also
been found in macrophages present in chronic inflamma-
tory lesions, such as human atherosclerotic plaques [13].
As in atherosclerosis, macrophages are key components
of renal inflammation [14]. Collectively, these observa-
tions plus the effects of 15dPGJ2 on kidney cells suggest
a potential regulatory role for J-series prostaglandins in
the kidney’s response to inflammation.
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During a survey of the mesangial cell proteome after
treatment with 15dPGJ2, we found heat shock protein 70
(HSP70) to be the most conspicuously up-regulated pro-
tein. Stress proteins protect cells against ischemic or toxic
injury and death and attenuate inflammation [15–17].
This raised the possibility that stress proteins are impor-
tant mediators or modulators of the effects of 15dPGJ2
on mesangial cells. Although cyclopentenones have pre-
viously been shown to activate hsp70 transcription in
various cells [18, 19], the mechanism of activation remains
unclear. Because of their unsaturated ketone groups, a
key feature of these prostaglandins is an electrophilic car-
bon in the cyclopentane ring that is highly reactive toward
intracellular thiols [4, 20–23]. The consequences of this
sulfhydryl reactivity on cell biology are potentially sig-
nificant. For example, binding to and decreasing reduced
glutathione (GSH) levels can lead to changes in cellular
redox status [24], a well-recognized signaling mechanism.
Alternatively, covalent modification of cysteine groups
can affect protein conformation and stability, enzymatic
activity, and transcription factor function [23, 25, 26].
The main activator of hsp70 is the transcription factor
heat shock factor 1 (HSF1) [27]. A recent study demon-
strated that the transcriptional activity of HSF1 is depen-
dent on disulfide formation between two of its cysteine
residues [28]. Thus HSF1 is a potential target for
modification by 15dPGJ2, either directly, or through a
15dPGJ2-mediated change in redox state. Similarly, other
stress-responsive transcription factors are regulated by
cysteine residues whose thiol groups act as sensors of cel-
lular perturbation. For example, the transcription factor
NF-E2-related factor 2 (Nrf2) is held inactively in the
cytoplasm by the regulatory protein Keap1 until thiol
groups on Keap1 are modified, releasing Nrf2 so it can
translocate to the nucleus [29, 30]. In the nucleus, Nrf2 in-
teracts with the electrophile response element (EpRE) in
the promoter of Nrf2-responsive genes, such as the stress
protein heme oxygenase-1 (HO-1), to activate transcrip-
tion [31]. Therefore, Nrf2 can potentially be activated by
15dPGJ2. Interestingly, inspection of the DNA sequence
upstream of the start codon of hsf1 demonstrates EpRE-
like sites between nucleotides −1926 and −1935, −933
and −924, −824 and −815, and −666 and −657 [32, 33],
suggesting the possibility of crosstalk between Nrf2 and
the HSF1-HSP70 pathway.
The current investigation was undertaken to determine
the mechanism of stress protein activation by 15dPGJ2
in human mesangial cells. We showed that a brief expo-
sure of mesangial cells to a noncytotoxic concentration of
15dPGJ2 was sufficient to induce HSP70, most likely at
the transcriptional level because 15dPGJ2 concomitantly
activated HSF1. HSP70 induction did not depend on gen-
eration of reactive oxygen species (ROS), but appeared to
be mediated through a mechanism involving direct mod-
ification of protein thiols. Additionally, 15dPGJ2 greatly
increased the activity of Nrf2 and up-regulated HO-1 lev-
els, providing further evidence for thiol modification as
a mechanism of 15dPGJ2 signaling. Finally, overexpres-
sion of Nrf2 in mesangial cells failed to increase HSP70
or HSF1 levels, suggesting the pathways are indepen-
dent. Because stress proteins like HSP70 and HO-1 are
cytoprotective and anti-inflammatory, the direct activa-
tion of stress-responsive transcription factors containing
regulatory thiol groups by electrophiles such as 15dPGJ2
suggests a novel therapeutic approach to inflammatory
kidney diseases.
METHODS
Cell culture and treatment
Human mesangial cells were cultured from adult kid-
neys not suitable for transplantation, and were character-
ized as previously described [34]. Cells from at least three
different donors were used between passages 4 and 7.
Unless otherwise indicated, cells were grown to 80% con-
fluence in RPMI 1640 containing 10% heat-inactivated
fetal bovine serum (FBS) (Gibco, Grand Island, NY,
USA). Twenty-four hours before treatment the FBS was
reduced to 0.5%, and all experiments were subsequently
done in RPMI 1640 plus 0.5% FBS. The human embry-
onal kidney cell line (HEK 293) and the human hepa-
toblastoma cell line (HEP G2) were also used in some
experiments. HEK 293 cells and HEP G2 cells were
grown in Dulbecco’s modified Eagle’s medium (DMEM)
plus 10% FBS (Gibco) until 80% confluent, and then
placed in media containing 0.5% FBS for 24 hours prior
to use. All experiments were subsequently done in media
containing 0.5% FBS.
Cells were treated as indicated with 15dPGJ2 or PGJ2
as solutions in methyl acetate (Cayman Chemical, Ann
Arbor, MI, USA). Other chemicals were purchased from
Sigma Chemical Co. (St. Louis, MO, USA) unless indi-
cated. In all experiments involving treatment of cells with
a reagent dissolved in an organic solvent, control cells
were treated with the organic solvent in the same con-
centration as the experimental cells.
Proteomic analysis of mesangial cell lysates
Human mesangial cells were treated overnight with
10 lmol/L 15dPGJ2 or methyl acetate. Total cellular
proteins were solubilized in a buffer containing urea
(8 mol/L), 3-[(3-cholamidopropyl) dimethylammonio]-1-
propanesulfonate (CHAPS) (4% wt/vol), Tris (40 mmol/
L), 1, 4-dithioerythritol (DTE) (65 mmol/L), leupeptin
(0.1 mg/mL), phenylmethylsulfonyl fluoride (PMSF)
(0.1 mg/mL), sodium azide (1 mmol/L in 1 mol/L Tris,
pH 6.8), along with 1.76% ampholytes appropriate for
the pH range [3–10] of the immobilized pH gradient
strips used for isoelectric focusing (IEF) (Genomics
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Solutions, Ann Arbor, MI, USA). The protein con-
centration of these preparations was measured with
the RC/DC Kit (BioRad, Hercules, CA, USA), which
is compatible with the buffer detergents and am-
pholytes. IEF was done with 150 lg of protein on 18 cm
linear pH gradient strips using the pHaser system
(Genomics Solutions). After IEF, the immobilized
pH gradient strips were equilibrated in 112 mmol/L
Tris/acetate, 5% sodium dodecyl sulfate (SDS), 0.01%
bromophenol blue, 50 mmol/L dithiothreitol (DTT) for
2 minutes, transferred to a 10% Duracryl gel (Genomics
Solutions), and electrophoresed for 41/2 hours at 4◦C. Af-
ter electrophoresis, the gels were fixed in 40% methanol
and stained overnight with the fluorescent protein stain
SYPRO Ruby (Molecular Probes, Eugene, OR, USA).
Protein spots of interest were manually cut from the gels
and submitted for analysis to The Ohio State University
Mass Spectrometry Core Facility. The proteins were
subject to in-gel trypsin digestion and matrix-assisted
laser desorption ionization-time of flight (MALDI-
TOF) mass spectrometry on a Bruker Reflex III mass
spectrometer. The resulting peptide mass fingerprints
were compared to the NCBI online protein database for
protein identification using the ProFound search engine
(http://129.85.19.192/profound bin/WebProFound.exe).
The ProFound program returns a Z statistic with each
protein match that compares search results to a ran-
dom match population. A Z score >1.65 was taken as
statistically significant (P < 0.05).
Detection of specific proteins in cell lysates
by immunoblotting
After the indicated treatments, cells were lysed and
lysates immunoblotted for specific proteins as done previ-
ously [6]. The protein content of the lysates was measured
with the DC protein assay (BioRad), and equal amount
of protein were loaded in each lane of the gels. The blots
were developed using an enhanced chemiluminescence
system (ECL) (Amersham, Arlington Heights, IL, USA).
A mouse monoclonal antibody to human HSP70 (Stress-
gen, Victoria, BC, Canada) was used to detect inducible
70 kD heat shock protein (HSP70). This antibody does
not cross-react with constitutive HSP70. Human HO-1
was detected with a rabbit polyclonal antibody that does
not cross-react with HO-2 (Stressgen). The transcription
factor heat shock factor 1 (HSF1) was labeled with a poly-
clonal rabbit antibody (Stressgen) that detects an 85 kD
protein in unstressed cells, and a 95 kD protein in stressed
cells, representing active HSF1. Nonimmune primary an-
tibodies were used to ensure specificity of the results
(not shown).
Measurement of mesangial cell proliferation, growth
arrest, and cell death
Mesangial cell proliferation and viability in response to
specific treatments was assessed as described elsewhere
[8], using the reduction of 3-(4,5-dimethylthiazol-2yl)-
5(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-
tetrazolium (MTS) to a formazan product as a measure
of the number of living cells (Cell Titer 96) (Promega,
Madison, WI, USA). Data are reported as a proliferation
index, calculated as the ratio of absorbance for a specific
treatment to the absorbance of control (vehicle-treated)
cells. In this way the control condition always has a
proliferation index of 1. A proliferation index greater
than 1 represents a gain of cells compared to control (cell
proliferation), whereas an index less than 1 represents
loss of cells compared to control (cell death).
Electrophoretic mobility shift analysis (EMSA)
of nuclear proteins
Activation of specific transcription factors was mea-
sured by EMSA of nuclear proteins, as we have previously
described [35]. The protein content of the nuclear ex-
tracts was measured with the DC protein assay (BioRad),
and equal amount of protein were loaded in each lane
of the gels. HSF1 was detected using a double-stranded
DNA probe (sense strand; 5′-GGCGAAACTTCT
GGAATATTCCCGAACTTTCAG-3′) that contained
the heat shock element of the human hsp70 promoter
(underlined) plus two additional heat shock factor recog-
nition sites (italics) to enhance binding to HSF1 [36]. Nrf2
was detected with a double-stranded DNA probe (5′-
CAGGGCTGAGCTAGCAGAGAG-3′, sense strand)
found between positions−939 and−918 of the 5′-flanking
region of hsf1. For the purposes of this investigation, the
5′-flanking region of hsf1 was defined as the 2000 bases
immediately upstream of the ATG codon found by align-
ing the known hsf1 cDNA sequence to the sequence of
chromosome 8 (AC110280). The underlined bases show
significant homology to the core consensus sequence (5′-
TGA(C/T)nnnGC(A/G)-3′) of the EpRE [32, 33, 37]. In
some experiments 2 lg of a rabbit polyclonal antibody to
Nrf2 (Santa Cruz Biotechnology, Santa Cruz CA, USA)
was added to the incubation mixture to verify the speci-
ficity of the retarded protein-oligonucleotide complex, as
described [35].
Determination of cellular thiols using a biamane probe
Intracellular thiols were measured by loading
appropriately treated cells with the thiol probe mono-
bromobimane (MBB) (Molecular Probes). MBB is
nonfluorescent until it reacts with thiols, and then it is
strongly fluorescent [38]. Addition of MBB to untreated
cells gives a fluorescent measurement that reflects total
(protein and nonprotein) cellular thiols. Cells treated
with reagents that decrease intracellular thiols or block
sulfhydryl groups will have a diminished fluorescent sig-
nal relative to untreated cells [38]. Mesangial cells grown
in 96-well plates were loaded with 40 lmol/L MBB for
Zhang et al: Induction of HSP70 and HO-1 by 15dPGJ2 801
60 minutes and then analyzed on a fluorescent mi-
croplate reader using an excitation wavelength of 360 nm
and an emission wavelength of 460 nm. Background
fluorescence was subtracted from all the readings, and
the data were expressed in arbitrary fluorescence units.
Plasmids, transfection, and reporter assays
A luciferase reporter construct under control of the
EpRE (5′-TGACTCAGCA-3′) from the human nicoti-
namide adenine dinucleotide phosphate (reduced form)
(NAD(P)H):quinone oxidoreductase-1 gene promoter
(p3 × ARE/Luc), a dominant negative Nrf2 expression
vector (pcDNA3DN-Nrf2), and a Keap-1 expression vec-
tor (pcDNA3Keap-1/Nrf2) were generated as previously
described [39].
To determine whether 15dPGJ2 activated EpRE-
dependent gene expression, HEK 293 cells were grown
to 90% confluence in 24-well plates and transfected with
0.5 lg of p3xARE/Luc using 8 lL of Lipofectamine 2000
(Invitrogen, Carlsbad, CA, USA) according to manu-
facturer’s instructions. pSV-b-galactosidase (0.5 lg/well)
was cotransfected to monitor transfection efficiency. In
some experiments, the cells were also co-transfected
with 1 lg of pcDNA3DN-Nrf2, pcDNA3Keap1/Nrf2, or
empty pcDNA3.0 vector. After 4 hours, cells were washed
and allowed to recover for 20 hours. Cells were then
left untreated (control), or were treated with 15dPGJ2
or methyl acetate. After 20 hours, cells were lysed and
luciferase activity measured using a luciferase reporter
assay system (Promega). Luciferase activity was normal-
ized to pSV-b-galactosidase activity.
Adenoviral transduction of human mesangial cells
An adenovirus encoding murine Nrf2 cDNA (Ad.
Nrf2) was made using the AdEasytm XL Adenoviral
Vector System (Stratagene, LaJolla, CA, USA), accord-
ing to manufacturer’s instructions. Briefly, the full-length
murine Nrf2 gene was cloned into the XbaI and NotI
sites of pShuttle-IRES-hrGFP-1, which contains a di-
cistronic transcript encoding human recombinant green
fluorescence protein (hrGFP) for monitoring the expres-
sion of Nrf2. To produce recombinant Ad.Nrf2, pShuttle-
IRES-hrGFP-Nrf2 was linearized with PmeI and
transformed into BJ5183-AD-1 cells. Ad.Nrf2 plasmid
was then linearized with Pac I and transfected into HEK
293 cells to generate Ad.Nrf2. The virus was amplified
in HEK 293 cells and purified on double cesium gradi-
ents. The viral construct was validated by Western blot-
ting of infected cells for Nrf2 (not shown), and func-
tionally by measuring its ability to induce expression of
transfected p3xARE/Luc. Ad.GFP, encoding hrGFP, was
used as a control. In HeLa cells 24 hours after infection,
EpRE-dependent luciferase activity was 4.6-fold higher
in cells infected with 100 multiplicity of infection (MOI)
of Ad.Nrf2 compared to cells infected with Ad.GFP
(P < 0.0001, N = 3).
Mesangial cells were plated at a density of 75,000 per
well in 6-well plates 24 hours before viral transduction.
Ad.GFP or Ad.Nrf2 were added at MOI of 50 or 100
in 1.0 mL of medium containing 2% FBS for 4 hours.
The medium was then changed back to 10% serum for
20 hours. Cells were harvested 24 hours after infection,
and lysates were probed for HSP70, HSF1, and HO-1 by
immunoblotting.
Statistical analysis
Data are presented as the mean ± standard error of
the mean, unless otherwise indicated. Multiple compar-
isons were examined for significant differences between
groups using analysis of variance (ANOVA), followed
by individual comparisons with the Bonferroni post-test.
Comparisons between two groups were made with the
Student t test. A P < 0.05 was considered significant.
RESULTS
Induction of HSP70 by J-series prostaglandins
A proteomic approach was used to identify candidate
proteins involved in mediating the effects of 15dPGJ2
on human mesangial cells. Mesangial proteins were iso-
lated after overnight treatment with 10 lmol/L 15dPGJ2
or methyl acetate, and separated by isoelectric point and
then molecular mass. Visual scanning of the resulting gels
consistently demonstrated enhanced protein expression
in one area of the gel after treatment with this cytotoxic
dose of 15dPGJ2 (Fig. 1, inset). Although the expres-
sion of other proteins was more subtly affected, initial
efforts focused on further characterizing this particular
protein. The protein spot was cut from the gel, analyzed
by MALDI-TOF mass spectrometry, and identified as
HSP70 (Fig. 1). This result was verified by immunoblot-
ting for HSP70 in lysates of mesangial cells treated with
15dPGJ2. As shown in Figure 2, overnight treatment with
15dPGJ2 caused a dose-dependent increase in mesan-
gial HSP70 expression that peaked in cells treated with
5 lmol/L 15dPGJ2, and decreased with higher concen-
trations. HSP70 levels increased rapidly after exposure
to 15dPGJ2 (within 6 h). Furthermore, HSP70 was still
elevated 24 hours after cells had been treated for only
1 hour with the prostaglandin (Fig. 2). PGJ2, the precur-
sor to 15dPGJ2 induced HSP70, but required an approxi-
mately fivefold higher dose to reach a level of expression
similar to that induced by 15dPGJ2. 15dPGJ2 also caused
up-regulation of HSP70 in other human cell lines (Fig. 3).
The induction of HSP70 by 15dPGJ2 coincided with
the activation of HSF1. Nuclear extracts from 15dPGJ2-
treated mesangial cells showed enhanced binding to a
probe containing the hsp70 heat shock element (Fig. 4).
Similar results were found using HEK 293 cells (not
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Fig. 1. Proteomic analysis of mesangial cell proteins after exposure
to 15-deoxy-∆12,14-prostaglandin J2 (15dPGJ2). Mesangial cells were
treated with solvent (control) or 10 lmol/L 15dPGJ2 for 18 hours, then
cells were lysed, and proteins separated by isoelectric focusing (first
dimension) followed by polyacrylamide gel electrophoresis (second di-
mension). The inset shows areas of interest from a representative set
of second dimension gels. The pH gradient for these gels was acidic
(pH 3)→basic (pH 10) from left to right. The arrow indicates a pro-
tein(s) that was qualitatively increased in response to 15dPGJ2 in three
separate experiments. This protein was digested in-gel with trypsin and
analyzed by matrix-assisted laser desorption ionization-time of flight
(MALDI-TOF) mass spectrometry. A representative mass spectrum
from two experiments is shown. Using the ProFound search engine,
this peptide mass fingerprint matched heat shock protein 70 (HSP70)
with a significant degree of confidence (Z-score = 2.43), and covered
19% of the protein sequence.
shown). Additionally, the immunoreactive HSF1 found
in the nuclei of cells exposed to 15dPGJ2 migrated more
slowly than HSF1 from untreated cells (Fig. 4), consis-
tent with the activated form of HSF1 [40]. Importantly,
although 15dPGJ2 is a ligand for the transcription fac-
tor peroxisome proliferator-activated receptor (PPAR)-c
[41], HSP70 was not induced by the thiazolidinedione
troglitazone, a specific PPAR-c agonist [42], and pre-
treatment with GW9662, a PPAR-c antagonist [43], did
not block the effect of 15dPGJ2 on HSP70 (Fig. 5).
Induction of HSP70 is associated with protection
against mesangial cell death
HSP70 is a cellular cytoprotectant. To determine if con-
ditions that favor up-regulation of HSP70 protect mesan-
gial cells against 15dPGJ2-mediated death, cells were
pulsed for up to 4 hours with 5 lmol/L 15dPGJ2 and then
allowed to recover for 20 hours in prostaglandin-free me-
dia. These cells, preconditioned to express a high level
of HSP70, were subsequently treated overnight with a
toxic dose of 15dPGJ2 (15 lmol/L). As shown in Figure 6,
preconditioning significantly attenuated the cell death in-
duced by high-dose prostaglandin. Similar results were
found using cells preconditioned with 10 lmol/L PGJ2
for 6 hours, allowed to recover prostaglandin-free for
18 hours, and then treated with 15 lmol/L 15dPGJ2 for
18 hours (proliferation index 0.4 ± 0.03 for cells treated
with 15 lmol/L 15dPGJ2 vs. 0.7 ± 0.08 for cells pretreated
with PGJ2, P < 0.015, N = 3).
HSP70 expression is a response to protein thiol
modification, but not oxidant stress
The electrophilic carbons of cyclopentenone pros-
taglandins readily react with sulfhydryl groups. Using
the thiol probe MBB, 15dPGJ2 was found to dose de-
pendently reduce mesangial free thiol levels (Fig. 7).
GSH levels, measured by high performance liquid chro-
matography (HPLC) or with a colorimetric recycling
assay, were diminished in mesangial cells treated with
15dPGJ2 in concentrations of 5 lmol/L and above (data
not shown). Thus, the observed reduction in MBB fluo-
rescence was attributable in part to GSH consumption
by 15dPGJ2. 15dPGJ2 also affected intracellular thiols
besides GSH, as illustrated by measuring the MBB fluo-
rescence of cells treated with the c-glutamylcysteine syn-
thetase inhibitor buthionine sulfoximine (BSO) alone,
or in combination with 15dPGJ2. As expected, deplet-
ing GSH with BSO reduced the total mesangial thiol
level by about 50% [38], but treatment of GSH-depleted
cells with 15dPGJ2 further reduced the thiol level (Fig. 7).
This was consistent with an effect of 15dPGJ2 on other
types of intracellular thiols, such as protein sulfhydryls.
The fall in GSH levels in 15dPGJ2-treated cells repre-
sents a potential signaling mechanism through changes
in redox potential that could activate HSP70 expres-
sion. To investigate this possibility, mesangial GSH was
depleted with BSO and HSP70 production was mea-
sured. As shown in Figure 8A, GSH depletion did not
activate HSP70 synthesis. Furthermore, mesangial cell
treatment with several mechanistically different antioxi-
dants was unable to attenuate 15dPGJ2-induced HSP70
expression (Fig. 8B). Ineffective antioxidants included
membrane-permeable superoxide anion and hydroxyl
radical scavengers (Tiron and Tempol), and lipid peroxi-
dation inhibitors (vitamin E, vitamin E acetate, Trolox, a
water-soluble vitamin E derivative, and a-tocotrienol). In
some experiments, catalase was overexpressed in mesan-
gial cells using an adenoviral construct, but this did not
affect 15dPGJ2-mediated HSP70 production (data not
shown). However, thiol-replenishing agents such as DTT,
N-acetyl cysteine (NAC), and a-lipoic acid decreased
HSP70 induction by 15dPGJ2 (Fig. 8B). Using densitome-
try, the average reduction in HSP70 levels was about 24%
with 3 mmol/L DTT and 50% with 5 mmol/L DTT. HSP70
was reduced by 37% and 48% with 100 lmol/L and
150 lmol/L lipoic acid, respectively. Five and 10 mmol/L
Zhang et al: Induction of HSP70 and HO-1 by 15dPGJ2 803
0 1 2.5 5 10 15  HrHSP70
Continuous exposure to 15dPGJ2, hours Pulse exposure to 15dPGJ2, hours
Pulse exposure to PGJ2, µmol/L
C 6 C 12 C 24 C 1 2 4 6 HrHSP70
C 15dPGJ2 1 5 10 25 C
15dPGJ2, µmol/L
Fig. 2. 15-deoxy-∆12,14-prostaglandin J2
(15dPGJ2) and prostaglandin J2 (PGJ2)
induce heat shock protein 70 (HSP70) pro-
duction by mesangial cells. Mesangial cells
were treated with J-series prostaglandins and
cell lysates were immunoblotted for HSP70.
Upper panel, cells were treated with the indi-
cated concentrations of 15dPGJ2 for 18 hours
before harvest. 15dPGJ2 increased HSP70
production in a dose-dependent fashion.
Human recombinant HSP70 (HrHSP70) was
included as a positive control (representative
of three experiments.) Middle panel, cells
were either continuously exposed to 5 lmol/L
15dPGJ2 for the indicated lengths of time
and then harvested, or were pulsed with the
prostaglandin for 1 to 6 hours, washed, and
placed in fresh, prostaglandin-free media to
complete a total 24 hour incubation before
lysis. Lower panel, cells were treated with
the indicated concentrations of PGJ2 for 4
hours, washed and placed in fresh media
for an additional 20 hours, and then lysed.
Lysates from cells pulsed with 5 lmol/L
15dPGJ2 for 4 hours, washed and placed in
fresh media for an additional 20 hours were
included for comparison (representative of
three experiments).
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Fig. 3. 15-deoxy-∆12,14-prostaglandin J2 15dPGJ2 induces heat shock
protein 70 (HSP70) production by other cell types. Human embryonal
kidney cell line (HEK 293) and human hepatoblastoma cell line (HEP
G2) cells were treated with the indicated concentrations of 15dPGJ2 and
cell lysates were immunoblotted for HSP70. In the blot shown for HEK
293, the cells were pulsed with the prostaglandin for 4 hours, washed,
placed in fresh media and harvested 20 hours later. Similar results were
obtained when HEK 293 cells were treated with 15dPGJ2 for 24 hours
continuously. In the blot shown for HEP G2 cells, the cells had been
treated with 15dPGJ2 continuously for 24 hours (representative of two
experiments).
NAC reduced HSP70 by 33% and 66%, respectively. In
contrast to the other types of antioxidants used, DTT,
NAC, and a-lipoic acid are able to directly reduce ox-
idized or modified protein thiols, raising the possibility
that 15dPGJ2-mediated HSP70 expression is a result of
covalent modification of protein sulfhydryls.
The consequence of directly modifying protein thiols
on HSP70 expression was investigated using phenylarsine
oxide (PAO), a trivalent arsenical that has a high affin-
ity for protein vicinal dithiols, but not monothiols [44].
PAO caused a dose-dependent increase in HSP70 levels in
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Fig. 4. 15-deoxy-∆12,14-prostaglandin J2 (15dPGJ2) induces heat
shock factor-l (HSF1) expression. Mesangial cells were treated with
10 lmol/L 15dPGJ2 for 3 hours prior to isolation of nuclei and har-
vest of nuclear proteins. Left panel, nuclear extracts were tested for
binding to an oligonucleotide probe containing the HSF1 recognition
sequence from the human hsp70 gene promoter by electrophoretic mo-
bility shift analysis (EMSA). The lane labeled Probe did not include
nuclear extract. The arrows show the position of HSF1 and unbound
oligonucleotide. To demonstrate the specificity of binding of the HSF1
oligonucleotide, 100-fold excess unlabeled HSF1 probe was used to
compete for binding to nuclear proteins from 15dPGJ2-treated cells
(Comp). Right panel, the nuclear proteins were immunoblotted with an
antibody specific for HSF1. The higher molecular mass HSF1 isoform
from 15dPGJ2-treated cells indicates activation of the transcription fac-
tor (representative of two experiments).
mesangial cells, HEK 293 cells, and HEP G2 cells (Fig. 9).
Interestingly, PAO also mimicked the concentration-
dependent effects of 15dPGJ2 on mesangial proliferation
and cell death [8], with low concentrations of PAO causing
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Fig. 5. Peroxisome prolifeator-activated receptor-c (PPAR-c) does
not mediate the effects of 15-deoxy-∆12,14-prostaglandin J2 (15dPGJ2)
on heat shock protein 70 (HSP70). Upper panel, mesangial cells were
treated with solvent (C), 15dPGJ2 (5 lmol/L), or the indicated concen-
trations of troglitazone for 4 hours, washed, and placed in fresh media
to complete a total of 24 hours of incubation. Cells were harvested and
lysates immunoblotted for HSP70 (representative of two independent
experiments). In a separate experiment (not shown), troglitazone in the
same concentration range was incubated with the cells continuously for
24 hours prior to immunoblotting for HSP70. The results were similar
to the 4-hour incubation. Lower panel, cells were treated with or with-
out the PPAR-c antagonist GW9662 (10 lmol/L) for 1 hour, followed
by solvent (C), or 15dPGJ2 (5 lmol/L) for 4 hours. The media was then
changed, and after 24 hours cell lysates were immunoblotted for HSP70
(representative of two independent experiments).
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Fig. 6. Preconditioning mesangial cells with low-dose 15-deoxy-
∆12,14-prostaglandin J2 (15dPGJ2) attenuates the cytotoxicity of high-
dose 15dPGJ2. Mesangial cells were pretreated with solvent (control)
or 5 lmol/L 15dPGJ2 for 1, 2, or 4 hours, washed, and placed in
fresh media to complete a total of 24 hours of incubation. Cells were
then treated with 15 lmol/L 15dPGJ2 for 18 hours. Cell viability was
assessed by 3-(4,5-dimethylthiazol-2yl)-5(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS) reduction, and the proliferation
index calculated as described in the Methods section. Each condition
was tested in three to seven individual experiments done in quadrupli-
cate. ∗P < 0.015; ∗∗P < 0.001 vs. control.
mesangial proliferation and higher concentrations caus-
ing cell death (Fig. 10).
15dPGJ2 activates the Nrf2-HO-1 pathway
The similar effects of 15dPGJ2 and PAO on HSP70
expression, cell proliferation, and cell death supports co-
valent protein thiol modification not only as a mechanism
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Fig. 7. 15-deoxy-∆12,14-prostaglandin J2 (15dPGJ2) modifies intracel-
lular thiols. Quiescent mesangial cells were untreated (control), or
treated with 50 lmol/L buthionine sulfoximine (BSO) overnight, methyl
acetate (MA), or 5, 10, or 20 lmol/L 15dPGJ2 for 4 hours. In some ex-
periments BSO treatment was followed by 15dPGJ2 (20 lmol/L) for 4
hours. Monobromobimane (MBB) was then added directly to the cells
and fluorescence measured after 60 minutes. Each condition represents
the average of eight replicates, and the experiment was repeated twice.
∗P < 0.001 vs. solvent control; ∗∗P < 0.001 vs. BSO alone and 15d-20.
for HSP70 induction, but as an important general mecha-
nism for 15dPGJ2 signaling. Additional evidence for sig-
naling through this mechanism was sought by examining
the thiol-regulated transcription complex Keap1-Nrf2,
and a downstream target gene HO-1, in 15dPGJ2-treated
cells. 15dPGJ2-mediated activation of Nrf2 was tested by
EMSA using an EpRE-containing oligonucleotide probe.
As shown in Figure 11A, nuclear extracts from 15dPGJ2-
treated cells had enhanced binding to the EpRE probe,
and nuclear protein-probe complexes could be super-
shifted in the presence of an antibody to Nrf2. In other
experiments, cells were transfected with an EpRE-driven
reporter construct and treated with 15dPGJ2. 15dPGJ2
significantly increased the promoter activity of this
construct (Fig. 11B). Furthermore, 15dPGJ2-mediated
induction of the EpRE reporter was abolished by co-
expressing a dominant-negative Nrf2, or attenuated
by overexpressing the cytoplasmic inhibitor Keap1
(Fig. 11B). As expected, identical results were obtained
with PAO (Fig. 11B). Finally, to verify that 15dPGJ2 could
up-regulate an Nrf2-dependent gene, mesangial, HEP
G2, and HEK 293 cells were immunoblotted for HO-1
after treatment with 15dPGJ2 or PAO. As shown in
Figure 12, the prostaglandin effectively induced HO-1 ex-
pression in all cell types tested, albeit with less apparent
potency than PAO.
Examining the possibility of an interaction between
Nrf2 and HSF1
Our data indicate the up-regulation of HSP70 and
HO-1 by 15dPGJ2 is mediated through activation of
the transcription factors HSF1 and Nrf2, respectively.
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Fig. 8. Role of oxidant stress in mesangial
heat shock protein 70 (HSP70) expression.
(A) Mesangial cells were treated for 24 hours
with the indicated concentrations of buthio-
nine sulfoximine (BSO) to deplete intra-
cellular glutathione (GSH), and cell lysates
were immunoblotted for HSP70. Lysates from
cells pulsed with 5 lmol/L 15-deoxy-12,14-
prostaglandin J2 (15dPGJ2) for 4 hours and
harvested at 24 hours were included for com-
parison. BSO had no effect on HSP70 pro-
duction (N = 2). (B) Mesangial cells were
preincubated with the indicated concen-
trations of specific antioxidants, and then
15dPGJ2 (5 lmol/L) was added for 4 hours.
After 4 hours, the cells were washed and
placed in fresh media for an additional 20
hours. Cell lysates were immunoblotted for
HSP70. The preincubation times were 1 hour
for Trolox, vitamin E derivatives, Tiron, and
Tempol, 10 to 30 minutes for dithiothreitol
(DTT), 2 hours for a-lipoic acid, and 1 hour for
N-acetyl cysteine (NAC). DTT, a-lipoic acid,
and NAC were washed off the cells before ad-
dition of 15dPGJ2. Each blot is representative
of two or more independent experiments.
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Fig. 9. Induction of heat shock protein 70 (HSP70) by modification
of protein vicinal dithiols. Cells were treated with phenylarsine oxide
(PAO) to modify protein vicinal dithiols (N = 2 for each cell type).
Mesangial cells [human mesangial cells (HMC)] and human embry-
onal kidney cell line (HEK 293) cells were treated with the indicated
concentrations of PAO for 4 hours, washed, and harvested at 24 hours;
human hepatoblastoma cell line (HEP G2) cells were treated with PAO
continuously for 24 hours before harvest.
Although these pathways are not known to interact, the
possibility of crosstalk between Nrf2 and HSF1 was exam-
ined because inspection of the DNA sequence upstream
of the start codon of hsf1 demonstrated several potential
EpRE sites. To determine whether Nrf2 could mediate
HSF1 and HSP70 expression, Nrf2 was overexpressed in
mesangial cells with an adenoviral construct. Despite the
presence of Nrf2 binding sites in the 5′-flanking region
of hsf1, Nrf2 did not affect HSF1 levels or HSP70 pro-
duction (Fig. 13). In contrast, overexpression of Nrf2 was
sufficient to increase HO-1 production (Fig. 13). Viral
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Fig. 10. Mesangial cell proliferation and death in response to pheny-
larsine oxide (PAO). Mesangial cells were incubated with the indi-
cated concentrations of PAO for either 24 hours, or pulsed for 4 hours,
washed, and incubated for an additional 20 hours. Cell viability was
assessed by 3-(4,5-dimethylthiazol-2yl)-5(3-carboxymethoxyphenyl)-2-
(4-sulfophenyl)-2H-tetrazolium (MTS) reduction, and the prolifera-
tion index calculated as described in the Methods section. ∗P < 0.001;
∗∗P < 0.01; ∗∗∗P < 0.05 vs. control.
infection per se did not contribute to this result, as over-
expression of GFP in mesangial cells did not affect HO-1
levels.
DISCUSSION
The present study demonstrates that treatment of cul-
tured human mesangial cells with the cyclopentenone
prostaglandin 15dPGJ2 elicits a stress response charac-
terized by the expression of HSP70 and HO-1. Although
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Fig. 11. 15-deoxy-∆12,14-prostaglandin J2 (15dPGJ2) induces nuclear
protein binding to the electrophile response element (EpRE) and
EpRE-driven promoter activity. (A) Mesangial cells or human em-
bryonal kidney cell line (HEK 293) cells were treated with 10 lmol/L
15dPGJ2 for 3 hours before harvest of nuclei and nuclear protein extrac-
tion. The nuclear extracts were tested for binding to an oligonucleotide
probe containing an electrophile response element (EpRE) from
the human hsf1 gene by elecrophoretic mobility shift analysis (EMSA).
The lane labeled Probe did not include nuclear extract. The arrows show
the position of Nrf2. Other bands are nonspecific. To demonstrate the
specificity of binding of the EpRE oligonucleotide, 100-fold excess unla-
beled EpRE probe was used to compete for binding to nuclear proteins
from 15dPGJ2-treated cells (15d + Comp). In some experiments an
antibody to Nrf2 (aNrf2) was added to the incubation mixture. SS indi-
cates the position of complexes supershifted in the presence of aNrf2
(representative of four individual experiments). (B) HEK 293 cells were
transfected with 1 lg of empty vector (pcDNA3.0) or expression vectors
for Keap1 or a dominant-negative mutant of Nrf2 (DN-Nrf2) plus 0.5
lg of p3 × ARE/Luc and 0.5 lg of b-galactosidase. After 4 hours, the
cells were washed and allowed to recover for 20 hours in fresh medium.
Cells were then treated with medium alone (untreated control cells),
solvent (control), 15dPGJ2 (7.5 lmol/L), or phenylarsine oxide (PAO)
(0.5 lmol/L) for 24 hours. Cell lysates were harvested and assayed for
luciferase activity, which was normalized to b-galactosidase activity. Re-
sults are expressed as fold changes over untreated cells. ∗P < 0.001 vs.
respective solvent control and vs. empty vector; ∗∗P < 0.01 vs. empty
vector (representative of three experiments done in triplicate).
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Fig. 12. 15-deoxy-∆12,14-prostaglandin J2 (15dPGJ2) and phenylar-
sine oxide (PAO) induce heme oxygenase 1 (HO-1) production. Mesan-
gial cells, human embryonal kidney cell line (HEK 293) cells, and human
hepatoblastoma cell line (HEP G2) cells were treated with the indicated
concentrations of 15dPGJ2 or PAO. Mesangial cells were treated for 4
hours, washed, and harvested at 24 hours, whereas HEK 293 cells and
HEP G2 cells were treated continuously for 24 hours. Cell lysates were
then immunoblotted for HO-1 (representative of three to four experi-
ments for each cell type).
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Fig. 13. Effect of overexpression of Nrf2 on stress protein expression
in mesangial cells. Mesangial cells were untreated (control), or in-
fected with adenovirus expressing green fluorescence protein (GFP)
(Ad.GFP) or Nrf2 (Ad.Nrf2) at 50 or 100 multiplicity of infection
(MOI). After 4 hours, the cells were washed and placed in fresh medium
for to complete 24 or 48 hours of total incubation. Whole cell lysates
were prepared and immunoblotted for heat shock protein 70 (HSP70),
heat shock factor-1 (HSF1), and heme oxygenase-1 (HO-1) (represen-
tative of two experiments).
15dPGJ2 is a PPAR-c agonist, this stress response ap-
pears to be independent of PPAR-c activation. Further-
more, the results indicate that induction of HSP70 and
HO-1 is secondary to covalent modification of protein
thiols by the prostaglandin, most likely due to the affin-
ity of the prostaglandin’s reactive carbons for sulfhydryls
[20, 45]. The evidence may be summarized as follows.
First, a proteomic survey of mesangial proteins altered
by 15dPGJ2 demonstrated that HSP70 was the most
conspicuously up-regulated protein. This was verified
by immunoblotting, as was 15dPGJ2-mediated HO-1
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expression. Second, 15dPGJ2 decreased intracellular free
thiols, including the antioxidant GSH. Although GSH de-
pletion can alter cellular redox status, and oxidant stress
can induce HSP70 in some types of cells, oxygen radical
scavengers or lipid peroxidation inhibitors did not pre-
vent 15dPGJ2-induced mesangial HSP70 expression, and
depleting GSH by blocking its synthesis did not increase
HSP70 levels. These findings suggest oxidant stress does
not play a major role in 15dPGJ2-mediated mesangial
HSP70 induction. Third, the arsenical PAO, which binds
with high affinity to vicinal protein dithiols and creates
modified dithioarsines, not only duplicated the effects of
15dPGJ2 on HSP70 and HO-1 expression, but also mim-
icked the effects of 15PGJ2 on mesangial cell proliferation
and death. Fourth, in GSH-depleted cells, 15dPGJ2 fur-
ther decreased free thiols, indicating reactivity with other
intracellular thiols, which are mainly protein thiols. Direct
binding of 15dPGJ2 to mesangial proteins has recently
been demonstrated, including the p50 component of nu-
clear factor-kappaB (NF-jB) through a cysteine residue
in its DNA binding domain [23, 26]. Using malignant cells,
it has been estimated that while GSH binds 70% of ad-
ministered PGJ2, 15% to 20% of the prostaglandin is con-
jugated to cellular proteins [22]. Fifth, thiol-replenishing
agents like DTT and lipoic acid, which can reverse or pre-
vent protein thiol modification (e.g., the binding of PAO
to vicinal dithiols [44]) attenuated the HSP70 response
to 15dPGJ2. Finally, 15dPGJ2 caused the transcription
factor Nrf2 to translocate to the nucleus, and also ac-
tivated an Nrf2-dependent reporter gene. Nrf2 activity
requires the inhibitory effect of its cytoplasmic regula-
tory protein Keap1 to be neutralized, which is accom-
plished through modification of specific sulfhydryl groups
on Keap1 [29, 30]. Overexpression of Keap1 decreased
15dPGJ2-mediated expression of the Nrf2-dependent
reporter.
Dose-response analysis demonstrated that 5 lmol/L
15dPGJ2, a noncytotoxic concentration of the pros-
taglandin [8], was the optimal dose for HSP70 induction,
and that doses of 1 to 2.5 lmol/L, which cause mesan-
gial proliferation [8], also effectively increased HSP70.
Because HSP70 can facilitate cell growth [46], increased
expression of this stress protein may partially contribute
to the proliferative effects of low-dose 15dPGJ2. Con-
centrations of 15dPGJ2 above 5 lmol/L begin to show
cytotoxicity [8], and the extent of mesangial cell survival
after exposure to higher doses of 15dPGJ2 likely reflects
a balance between toxicity of the prostaglandin and the
anti-apoptotic activity of HSP70 [47, 48]. HSP70 levels
declined in mesangial cells treated with 10 to 15 lmol/L
15dPGJ2, possibly reflecting translocation and loss of
HSP70 from the cell surface of terminally apoptotic cells,
as previously described [49].
Brief exposure (1 to 4 hours) to a noncytotoxic dose
(5 lmol/L) of 15dPGJ2 was sufficient to elevate HSP70
for at least 24 hours, suggesting that 15dPGJ2 precondi-
tioning could enhance cell survival to subsequent toxic ex-
posures. As has been shown for other treatments that in-
crease HSP70 (47, 50–52), mesangial cells preconditioned
with low-dose 15dPGJ2 did show significant protection
against cell death when reexposed to toxic concentra-
tions of 15dPGJ2. A similar protective effect of low-dose
15dPGJ2 was noted for variety of cytotoxic lipid deriva-
tives [53, 54]. The parent prostaglandin PGJ2 also induced
HSP70 and provided protection against cell death. This
may be important if J-series prostaglandins are eventu-
ally used therapeutically for glomerular protection, be-
cause PGJ2 appears to be less toxic to mesangial cells
than 15dPGJ2 [8].
The protective effect of 15dPGJ2 is interesting in light
of 15dPGJ2-induced thiol consumption, which could ren-
der the cell more susceptible to oxidant injury. Conceiv-
ably, any deleterious effects of low-dose, short-duration
15dPGJ2 exposure on intracellular antioxidants are out-
weighed by the production of cytoprotective factors.
Mediators of 15dPGJ2-induced cytoprotection are prob-
ably not limited to HSP70 and HO-1, but likely include
other HSF1- and Nrf2-dependent stress proteins. Addi-
tionally, thiol depletion by low-dose 15dPGJ2 is modest,
so a potential decline in intracellular antioxidants may be
balanced by a concomitant induction of Nrf2-dependent
enzymes that regulate GSH synthesis [37]. In contrast,
prolonged treatment with high prostaglandin concentra-
tions causes more extreme thiol depletion, which likely
overwhelms cytoprotective mechanisms, and facilitates
oxidant stress.
15dPGJ2-induced mesangial HSP70 production was
accompanied by activation of HSF1 and increased HSF1
in the nucleus, consistent with transcriptional activation
of hsp70, as previously reported [18, 19]. 15dPGJ2-
mediated HO-1 production was also initiated at the
transcriptional level, through activation of Nrf2, a tran-
scription factor that is necessary and sufficient (see
Fig. 13) for HO-1 expression. In the case of HO-1 and
Nrf2, it is likely that the protein undergoing thiol modi-
fication by 15dPGJ2 is the cytoplasmic inhibitor Keap1.
Conjugation of electrophiles to Keap1 through certain
cysteine groups causes the release and nuclear translo-
cation of Nrf2 [30, 55]. The specific protein modified by
15dPGJ2 to initiate HSP70 production is likely HSF1. A
recent study demonstrated two critical cysteine residues
in the DNA-binding domain of HSF1 that are required
to form disulfide bonds for HSF1 to transactivate HSP70
in response to heat or oxidant stress [28]. In that re-
port, it was postulated that the formation of these disul-
fide bonds facilitates, or is directly involved in the ho-
motrimerization of constitutively expressed HSF1, result-
ing in activation of the transcription factor [28]. It is con-
ceivable that 15dPGJ2, with its two electrophilic carbons,
covalently modifies these two HSF1 cysteine residues,
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causing a conformational change similar to that of disul-
fide bridging.
We also explored the possibility that Nrf2 activation
by 15dPGJ2 could contribute to HSP70 induction by en-
hancing transcription of hsf1. This was prompted by two
observations. First, a previous investigation reported that
up-regulation of HSF1 nuclear binding and transcrip-
tional activity by the cyclopentenone prostaglandin
PGA1 required new protein synthesis [19]. Second, hsf1
has several potential Nrf1 binding sites in its 5′-flanking
region. Overexpression of Nrf2 in mesangial cells was not,
however, sufficient to activate the HSF1-HSP70 path-
way. Furthermore, a luciferase reporter driven by the 5′-
flanking region of hsf1 displayed high constitutive activ-
ity that was not increased by 15dPGJ2 treatment (Rovin
and Zhang, unpublished observation). Thus the Nrf2 and
HSF1 pathways appear to be independent.
In addition to covalent modification of protein dithi-
ols, another potential explanation for 15dPGJ2-mediated
stress protein induction is oxidation of protein thiols. In-
creased oxidant stress and lipid peroxidation have been
observed in some 15dPGJ2-treated cell types [24], and
GSH depletion could predispose to protein thiol oxida-
tion [56]. As indicated previously, oxidation of specific
cysteine residues of HSF1 leads to intra- or intermolec-
ular disulfide bond formation and activates HSF1 [28].
Alternatively, generalized protein thiol oxidation result-
ing in the formation of nonnative disulfides, has been
postulated to cause proteins to denature and aggregate;
thereby leading to HSF1 activation [25, 57]. Other inves-
tigations have shown significant induction of HSP70 by
large concentrations of H2O2 [28, 58]. Although 15dPGJ2
did lower mesangial GSH, as has been observed in other
cell types [24], oxidant stress does not appear to be the
main mediator of HSP70 induction by 15dPGJ2 in hu-
man mesangial cells. GSH depletion with BSO did not
increase HSP70 expression, and overexpression of cata-
lase or pretreatment with a number of oxygen radical
scavengers and lipid peroxidation inhibitors did not ab-
rogate the heat shock response to 15dPGJ2. Interestingly,
the stress response to oxidant injury may be cell-specific.
Rat hepatocytes treated with H2O2 showed only a small
increase in HSP70 content [59], and oxidant injury gen-
erated by xanthine-xanthine oxidase did not enhance
mesangial HSP70 [52].
The involvement of HSP70 and HO-1 in kidney dis-
ease has been most extensively studied in the con-
text of nephrotoxic or ischemic tubular injury. These
stress proteins were up-regulated in tubular epithelial
cells and appeared to provide protection against apop-
tosis and necrosis [15, 16, 60, 61]. The role of HSP70
and HO-1 in glomerular injury is less clear, but data
from several investigations suggest they mediate survival
and anti-inflammatory functions. For example, cytokine
treatment of mesangial cells or glomeruli in vitro de-
creased HSP70 expression and was associated with in-
creased apoptosis in response to oxidant stress [62]. In
vivo, glomeruli from animals with anti-glomerular base-
ment membrane (GBM) glomerulonephritis showed de-
creased HSP70 levels, presumably from the cytokine
milieu, and glomerular cells displayed increased apop-
tosis compared to control animals [62]. Pharmacologic
up-regulation of HO-1 in rodents with anti-GBM
glomerulonephritis decreased glomerular levels of in-
ducible nitric oxide synthase and proteinuria [63].
Nrf2 deficiency, which could potentially result in HO-1
deficiency, induced autoantibody production and a
glomerulonephritis similar to that of systemic lupus ery-
thematosus in aging mice [64].
In conclusion, low-dose, non-toxic concentrations of
15dPGJ2 induce stress proteins in mesangial cells by
directly modifying regulatory thiol groups of stress-
response transcription factors, which enhances their tran-
scriptional activity. Significant cell injury does not appear
to be required for this stress response. Up-regulation of
stress proteins protects mesangial cells against cell death.
Additionally, very recent reports show that HSP70 and
HO-1 contribute substantially to the anti-inflammatory
effect of 15dPGJ2 [65, 66]. Thus, manipulation of en-
dogenous J-series prostaglandins, or administration of
exogenous J-series prostaglandins may be beneficial in
attenuating glomerular injury and inflammation during
kidney disease.
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